Do higher costs mean better care? In some markets, yes

Receiving care from hospitals with higher inpatient prices leads to a 35 percent reduction in in-hospital mortality, but this relationship is mostly only true in relatively unconcentrated markets, according to a study by the National Bureau of Economic Research.

Advertisement

The analysis uses data from the Health Care Cost Institute. 

Unconcentrated markets with higher inpatient prices have a 1.37 percentage point decrease in mortality, a 53 percent increase in spending on emergency services and a 22 percent increase in one-year total health spending.

This proves these hospitals are spending an additional $1 million on nondeferrable emergency cases for every life that is saved, according to the study authors, who note the spending is likely cost-effective.

However, hospitals in highly concentrated markets with higher prices were not found to have lower mortality rates.

Read more here.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.